These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 7941590)

  • 1. [Bronchial cancer--development, diagnosis, therapy, prognosis].
    Zöchbauer S; Krajnik G; Huber H
    Wien Klin Wochenschr; 1994; 106(14):431-47. PubMed ID: 7941590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendations on the therapy of bronchial carcinoma].
    Thomas M; Baumann M; Deppermann M; Freitag L; Gatzemeier U; Huber R; Passlick B; Serke M; Ukena D
    Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality therapy of lung cancer.
    Livingston RB
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchial cancer--adjuvant chemotherapy].
    Drings P
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():89-94. PubMed ID: 1983675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of survival and prognostic factors of 2,000 broncho-pulmonary cancers registered during 10 years in a multidisciplinary oncology department].
    Moro D; Nagy-Mignotte H; Bolla M; Colonna M; Brichon PY; Brambilla C; Schaerer R; Vrousos C
    Bull Cancer; 1997 Feb; 84(2):155-61. PubMed ID: 9180838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New therapeutic strategies and current research in inoperable locally advanced non small-cell lung cancers (stage IIIB)].
    Le Cesne A; Arriagada R; Grunenwald D; Baldeyrou P; Girard P; Bretel JJ; Le Chevalier T
    Bull Cancer; 1997 Apr; 84(4):413-9. PubMed ID: 9238166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of haemoglobin levels on prognosis and quality of life of patients with bronchial carcinoma].
    Drings P; Wannenmacher M
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1507-11. PubMed ID: 15942841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival?
    Wang T; Nelson RA; Bogardus A; Grannis FW
    Cancer; 2010 Mar; 116(6):1518-25. PubMed ID: 20108308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histology and prognosis in lung cancer treatment].
    Kodama T; Nishiyama H; Nishiwaki Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):216-24. PubMed ID: 2162441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors and therapeutic strategy in non-small-cell bronchial carcinoma].
    Wolf M
    Praxis (Bern 1994); 1997 Oct; 86(42):1640-6. PubMed ID: 9432685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung cancer].
    Alexandersen O
    Tidsskr Nor Laegeforen; 2001 Feb; 121(4):407-9. PubMed ID: 11255851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in surgical therapy of bronchus carcinoma].
    Ris HB; Eigenmann V; Signer C; Betticher DC; Gugger M; von Briel C
    Ther Umsch; 1998 Jul; 55(7):394-8. PubMed ID: 9702101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical therapy for carcinoma of the lung.
    Shields TW
    Clin Chest Med; 1993 Mar; 14(1):121-47. PubMed ID: 8384959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial.
    Eberhardt W; Stamatis G; Stuschke M; Wilke H; Müller MR; Kolks S; Flasshove M; Schütte J; Stahl M; Schlenger L; Budach V; Greschuchna D; Stüben G; Teschler H; Sack H; Seeber S
    Br J Cancer; 1999 Dec; 81(7):1206-12. PubMed ID: 10584883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB of non-small-cell bronchial carcinoma (the Essen concept)].
    Eberhardt W
    Praxis (Bern 1994); 1997 Oct; 86(42):1647-53. PubMed ID: 9432686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.